InsidersTradesSigma
Follow the Biogen Pharmachem stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €294.9m. The latest transaction was disclosed on 27 May 2026 (Disposal). Among the most active insiders: Interface Financial Services Ltd. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Biogen Pharmachem 是一家专门从事药品和化学产品制造的公司。该公司在 XBOM 市场运营。